A Human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo

Characterization of the Cross-Neutralizing Antibody Response Against Hepatitis C Virus in the Liver Transplantation Setting

(2011) J. Dragun et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Effect of the Hepatitis C Virus Protease Inhibitor Telaprevir on the Pharmacokinetics of Amlodipine and Atorvastatin

(2011) Jee Eun Lee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation

(2011) Viet Loan Dao Thi et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

The Results of Phase III Clinical Trials With Telaprevir and Boceprevir Presented at the Liver Meeting 2010: A New Standard of Care for Hepatitis C Virus Genotype 1 Infection, But With Issues Still Pending

(2011) Jean–Michel Pawlotsky   GASTROENTEROLOGY

Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus

(2011) Varun Garg et al.   HEPATOLOGY

Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents - A potentially lethal cocktail

(2011) Michael Charlton   HEPATOLOGY

Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells

(2011) Linda Andrus et al.   HEPATOLOGY

In vivoevaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus

(2011) Philip Meuleman et al.   HEPATOLOGY

PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus

(2011) Natalie Bzowej et al.   LIVER TRANSPLANTATION

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

(2011) Joachim Lupberger et al.   NATURE MEDICINE

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

(2011) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

(2011) Bruce R. Bacon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation

(2010) P. Guillouche et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Characterization of Human Liver Enzymes Involved in the Biotransformation of Boceprevir, a Hepatitis C Virus Protease Inhibitor

(2010) A. Ghosal et al.   DRUG METABOLISM AND DISPOSITION

Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human Hepatocytes

(2010) Isabel Fofana et al.   GASTROENTEROLOGY

Hepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kinetics

(2010) Laura Mensa et al.   HEPATOLOGY

Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation

(2010) Samira Fafi-Kremer et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Challenge Pools of Hepatitis C Virus Genotypes 1–6 Prototype Strains: Replication Fitness and Pathogenicity in Chimpanzees and Human Liver–Chimeric Mouse Models

(2010) Jens Bukh et al.   JOURNAL OF INFECTIOUS DISEASES

Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes

(2010) D. Bankwitz et al.   JOURNAL OF VIROLOGY

Neutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission

(2010) C. L. Brimacombe et al.   JOURNAL OF VIROLOGY

Hypervariable Region 1 Differentially Impacts Viability of Hepatitis C Virus Strains of Genotypes 1 to 6 and Impairs Virus Neutralization

(2010) J. Prentoe et al.   JOURNAL OF VIROLOGY

Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system

(2010) Christopher T Jones et al.   NATURE BIOTECHNOLOGY

Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures

(2010) A. Ploss et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Role of lipid metabolism in hepatitis C virus assembly and entry

(2009) Costin-Ioan Popescu et al.   BIOLOGY OF THE CELL

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors

(2009) M. J. Chapman et al.   EUROPEAN HEART JOURNAL

Hepatitis C virus cell entry: role of lipoproteins and cellular receptors

(2009) M. E. Burlone et al.   JOURNAL OF GENERAL VIROLOGY

Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants

(2009) M. T. Catanese et al.   JOURNAL OF VIROLOGY

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

(2009) Alexander Ploss et al.   NATURE

Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes

(2009) Kathie-Anne Walters et al.   PLoS Pathogens

Receptor Complementation and Mutagenesis Reveal SR-BI as an Essential HCV Entry Factor and Functionally Imply Its Intra- and Extra-Cellular Domains

(2009) Marlène Dreux et al.   PLoS Pathogens

The human liver-uPA-SCID mouse: A model for the evaluation of antiviral compounds against HBV and HCV

(2008) P MEULEMAN et al.   ANTIVIRAL RESEARCH

Early steps of the hepatitis C virus life cycle

(2008) Jean Dubuisson et al.   CELLULAR MICROBIOLOGY

Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted

(2008) Elizabeth C. Verna et al.   Clinics in Liver Disease

Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver–chimeric mice from infection with a homologous hepatitis C virus strain

(2008) Thomas Vanwolleghem et al.   HEPATOLOGY

Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo

(2008) Philip Meuleman et al.   HEPATOLOGY

Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs

(2008) Judith M. Gottwein et al.   HEPATOLOGY

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells

(2008) J. Witteveldt et al.   JOURNAL OF GENERAL VIROLOGY

Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies

(2008) J. Grove et al.   JOURNAL OF VIROLOGY